AstraZeneca Says they Found No Evidence of Increased Blood Clots from the Vaccine
According to a review of safety data done on Sunday, AstraZeneca Plc said there was no evidence of increased risk of blood clots in people vaccinated with its Covid-19 Vaccine.
Gathogo Wanjiru 
AstraZeneca’s review which covered more than 17 Million people vaccinated in the UK and the European Union comes after several countries suspended the use of its vaccine over claims of blood clotting.
“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and the UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, and batch or in any particular country,” the company said.
Health Authorities in Denmark, Iceland, Norway, Ireland, and the Netherlands have suspended the use of AstraZeneca over claims of blood clotting.
In Austria, they halted the use of a batch of AstraZeneca shots last week to investigate the death related to coagulation disorders.
Retired British Government Consultant in Communicable Disease Peter English told Reuters that, “It is most regrettable that countries have stopped vaccination on such ‘precautionary’ grounds: it risks doing real harm to the goal of vaccinating enough people to slow the spread of the virus, and to end the pandemic.”
According to the European Medicine Agency, there is no indication that the events were caused by the AstraZeneca vaccine a view echoed by World Health Organization (WHO) on Friday.
The AstraZeneca vaccine made in collaboration with Oxford University has been authorized for use in the EU and in many other countries worldwide but not yet authorized by the US regulators.
